These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hormonal therapy (medical orchiectomy) in prostatic carcinoma]. Studer UE; Münch D Schweiz Med Wochenschr; 1990 Jun; 120(24):881-7. PubMed ID: 2193381 [TBL] [Abstract][Full Text] [Related]
3. [Possibilities in drug therapy in prostatic carcinoma]. Schmid HP Ther Umsch; 1995 Jun; 52(6):418-22. PubMed ID: 7541571 [TBL] [Abstract][Full Text] [Related]
4. Endocrine treatment of prostate cancer: standard treatment and new perspectives. Boccardo F; Pace M In Vivo; 1993; 7(5):423-4. PubMed ID: 8110985 [TBL] [Abstract][Full Text] [Related]
7. [Hormone therapy for prostate cancer]. Théodore C Bull Cancer; 2004 Jan; 91(1):69-74. PubMed ID: 14975807 [TBL] [Abstract][Full Text] [Related]
8. Hormonal treatment in prostate cancer. Zbranca E; Preda C Endocrinologie; 1991; 29(1-2):91-7. PubMed ID: 1803495 [TBL] [Abstract][Full Text] [Related]
9. Compliance with hormonal treatment for prostate cancer. Kaisary AV Br J Hosp Med; 1996 Mar 20-Apr 2; 55(6):359-66. PubMed ID: 8696636 [TBL] [Abstract][Full Text] [Related]
10. Complete androgen blockade for the treatment of prostate cancer. Labrie F; Dupont A; Belanger A Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740 [No Abstract] [Full Text] [Related]
11. Endocrine therapy for prostate cancer. Damber JE Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920 [TBL] [Abstract][Full Text] [Related]
12. Hormonal therapy of prostate cancer: current concepts and future prospects. Smith JA Clin Ther; 1988; 10(3):281-6. PubMed ID: 3078908 [TBL] [Abstract][Full Text] [Related]
13. Combined androgen blockade: the gold standard for metastatic prostate cancer. McLeod DG; Crawford ED; DeAntoni EP Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789 [TBL] [Abstract][Full Text] [Related]
14. The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium. Mikkola A; Ruutu M; Aro J; Rannikko S; Salo J Ann Chir Gynaecol; 1999; 88(1):18-21. PubMed ID: 10230677 [TBL] [Abstract][Full Text] [Related]
15. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer. Scherr DS; Pitts WR J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759 [TBL] [Abstract][Full Text] [Related]
16. Current treatment of advanced prostate cancer. Ismail M; Gomella LG Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220 [TBL] [Abstract][Full Text] [Related]
17. Advanced prostate cancer: what's new in hormonal manipulation? Brewster SF; Gillatt DA Br J Hosp Med; 1993 May 19-Jun 1; 49(10):710-1, 714-5. PubMed ID: 7686805 [TBL] [Abstract][Full Text] [Related]
18. Hormonal therapy in prostatic carcinoma. Resnick MI Urology; 1984 Nov; 24(5 Suppl):18-23. PubMed ID: 6388092 [TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy for prostate cancer. Labrie F Endocrinol Metab Clin North Am; 1991 Dec; 20(4):845-72. PubMed ID: 1778180 [TBL] [Abstract][Full Text] [Related]
20. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer]. Tsukamoto S; Akaza H Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]